francis hunter, phd mesopharm therapeutics, inc
TRANSCRIPT
![Page 1: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/1.jpg)
Francis Hunter, PhD
Mesopharm Therapeutics, Inc.
![Page 2: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/2.jpg)
Entrepreneurship is a Team Sport
Co-Founder, CEO BTech, PhD
Liggins Institute Business Development
Plant & Food Founder & CEO
Lab Trader NZ Fulbright Scholarship
MBA Stanford GSB
![Page 3: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/3.jpg)
Breast Cancer Startup Challenge
![Page 4: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/4.jpg)
200 teams 83 universities 4,356 years of experienceVenture capitalists, seasoned entrepreneurs, clinicians
scientists, consultants, life science executives
Breast Cancer Startup Challenge
![Page 5: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/5.jpg)
Commercial development plan 130 pages Product and R&D strategy Commercialisation and regulatory strategies Market, IP and competition analyses Financial models Operational strategy
Live pitch
Online elevator pitch
Breast Cancer Startup Challenge
![Page 6: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/6.jpg)
Breast Cancer Startup Challenge
![Page 7: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/7.jpg)
Breast Cancer Startup Challenge
![Page 8: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/8.jpg)
Mesopharm Therapeutics, Inc. (DE C-Corp)
Mesopharm Therapeutics NZ Limited
![Page 9: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/9.jpg)
Armed Antibody Therapeutic
Monoclonal antibody
Highly cytotoxic drugAlpha particle (Actinium-225)
![Page 10: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/10.jpg)
ADC IND Submissions to the FDA
KadcylaPeak sales US $2–5BGenentech/RocheAdcetris
Peak sales US $1B+Seattle Genetics
![Page 11: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/11.jpg)
Networking Matters
![Page 12: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/12.jpg)
ONESTART Accelerator
![Page 13: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/13.jpg)
Francis Hunter Graeme Fielder
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2015
2003
B.Tech
Ph.D.
MBA (Stanford)
Plant & Food BD
Industry Liaison
Industry Liaison
CEO
Chair
Research Lead
CEO
Chair
Ph.D.
Hons.
B.Sc.
Challenges Lead
Education Lead
Participant
Participant
Judge
Research Fellow
Technical & Entrepreneurial Training
![Page 14: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/14.jpg)
Experienced Advisors Are Essential
Thorsten Melcher, PhDSenior DirectorJohnson & Johnson Innovation
Thorsten Melcher, MD PhDFounder & CEOLa Jolla Pharmaceuticals
Jeanette Wood, PhDCSOGenkyotex
Jilly Evans, PhDCo-Founder & CSOPharmAkea
Leon Chen, PhD MBAPartnerOrbiMed
Michael Kolodziej, MDNational Oncology DirectorAetna
Tom John, MBBS PhDHead of Thoracic OncologyAustin Hospital
![Page 15: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/15.jpg)
NZ, US, AusR&D
Best-in-classtherapeutics
Management& advisory
strength
![Page 16: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/16.jpg)
Enter the Spark Challenge!
![Page 17: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/17.jpg)
In-Licensing Technology
Leverage
![Page 18: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/18.jpg)
Starting Up by Licensing
ibridgenetwork.org – 18,000 patents 15,000 new patents filed by US universities
in FY2013
![Page 19: Francis Hunter, PhD Mesopharm Therapeutics, Inc](https://reader035.vdocuments.site/reader035/viewer/2022081506/56649ddd5503460f94ad63ca/html5/thumbnails/19.jpg)
Starting Up by Licensing: Playbook
Define a PROBLEM (=MARKET) RESEARCH the problem and possible solutions Identify technology PATENTS Choose your top 5 and become a
TERRIBLE EXPERT Approach the inventors and licensing
institution Select your best tech: Impact and maturity Build your TEAM, then LICENSE